Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Taisho discovers potent and selective CRF1 receptor antagonists with anxiolytic effects

Sep. 4, 1998

P&U, U of Maryland describe inhibitors of kynurenine aminotransferase

Sep. 4, 1998

Neuroprotective and antioxidant phenazines designed at Nippon Chemiphar

Sep. 4, 1998

Regeneron receives milestone payment from Sumitomo related to BDNF development

Sep. 4, 1998

Pfizer/Neurogen anxiolytic advances in clinical trials

Sep. 3, 1998

Pharmacological profile of new acetylcholinesterase inhibitor: T-82

Sep. 3, 1998

Therapeutics for cerebrovascular disorders in development at Nippon Chemiphar

Sep. 3, 1998

Compounds interacting with nicotinic receptors for cognitive and memory deficits

Sep. 2, 1998

Anticonvulsant benzamides prepared at SKB

Sep. 2, 1998

Cambridge NeuroScience announces advances in MS program

Sep. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...